Polycythemia vera epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of polycythemia vera is 48-57 cases per 100,000 individuals in the United States. This represents the age-adjusted prevalence as of 2010. | |||
The prevalence of polycythemia vera is 5-30 cases per 100,000 individuals in Europe.<ref name="pmid25353086">{{cite journal| author=Verstovsek S, Komrokji RS| title=Novel and emerging therapies for the treatment of polycythemia vera. | journal=Expert Rev Hematol | year= 2015 | volume= 8 | issue= 1 | pages= 101-13 | pmid=25353086 | doi=10.1586/17474086.2015.972359 | pmc=4934659 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25353086 }} </ref> | |||
===Age=== | ===Age=== | ||
Polycythemia vera occurs in all age groups (including children). The incidence increases with age. Polycythemia vera commonly affects people older than 60.<ref name="seercancergov">National Cancer Institute. Polycythemia vera 2015.http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd538d/</ref><ref>{{cite journal | author = Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A, Brusamolino E, Bonfichi M, Arcaini L, Caberlon S, Pascutto C, Lazzarino M | title = Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. | journal = Haematologica | volume = 88 | issue = 1 | pages = 13-8 | year = 2003 | id = PMID 12551821}}</ref><ref name="pvsg">Berlin, NI. (1975). "Diagnosis and classification of polycythemias". ''Semin Hematol'' '''12''': 339.</ref> | The average age of polycythemia vera is 55.<ref name="pmid25353086">{{cite journal| author=Verstovsek S, Komrokji RS| title=Novel and emerging therapies for the treatment of polycythemia vera. | journal=Expert Rev Hematol | year= 2015 | volume= 8 | issue= 1 | pages= 101-13 | pmid=25353086 | doi=10.1586/17474086.2015.972359 | pmc=4934659 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25353086 }} </ref> Polycythemia vera occurs in all age groups (including children). The incidence increases with age. Polycythemia vera commonly affects people older than 60.<ref name="seercancergov">National Cancer Institute. Polycythemia vera 2015.http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd538d/</ref><ref>{{cite journal | author = Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A, Brusamolino E, Bonfichi M, Arcaini L, Caberlon S, Pascutto C, Lazzarino M | title = Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. | journal = Haematologica | volume = 88 | issue = 1 | pages = 13-8 | year = 2003 | id = PMID 12551821}}</ref><ref name="pvsg">Berlin, NI. (1975). "Diagnosis and classification of polycythemias". ''Semin Hematol'' '''12''': 339.</ref> | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with polycythemia vera than females.<ref name="seercancergov">National Cancer Institute. Polycythemia vera 2015.http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd538d/</ref> | Males are more commonly affected with polycythemia vera than females.<ref name="seercancergov">National Cancer Institute. Polycythemia vera 2015.http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd538d/</ref><ref name="pmid25353086">{{cite journal| author=Verstovsek S, Komrokji RS| title=Novel and emerging therapies for the treatment of polycythemia vera. | journal=Expert Rev Hematol | year= 2015 | volume= 8 | issue= 1 | pages= 101-13 | pmid=25353086 | doi=10.1586/17474086.2015.972359 | pmc=4934659 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25353086 }} </ref> | ||
==References== | ==References== | ||
Revision as of 19:11, 12 February 2018
|
Polycythemia vera Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polycythemia vera epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Polycythemia vera epidemiology and demographics |
|
Risk calculators and risk factors for Polycythemia vera epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of polycythemia vera is approximately 0.7 to 2.6 per 100,000 individuals in the US.[1]
Epidemiology and Demographics
Incidence
The incidence of polycythemia vera is approximately 0.7 to 2.6 per 100,000 individuals in the US.[1]
Prevalence
The prevalence of polycythemia vera is 48-57 cases per 100,000 individuals in the United States. This represents the age-adjusted prevalence as of 2010. The prevalence of polycythemia vera is 5-30 cases per 100,000 individuals in Europe.[2]
Age
The average age of polycythemia vera is 55.[2] Polycythemia vera occurs in all age groups (including children). The incidence increases with age. Polycythemia vera commonly affects people older than 60.[1][3][4]
Gender
Males are more commonly affected with polycythemia vera than females.[1][2]
References
- ↑ 1.0 1.1 1.2 1.3 National Cancer Institute. Polycythemia vera 2015.http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd538d/
- ↑ 2.0 2.1 2.2 Verstovsek S, Komrokji RS (2015). "Novel and emerging therapies for the treatment of polycythemia vera". Expert Rev Hematol. 8 (1): 101–13. doi:10.1586/17474086.2015.972359. PMC 4934659. PMID 25353086.
- ↑ Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A, Brusamolino E, Bonfichi M, Arcaini L, Caberlon S, Pascutto C, Lazzarino M (2003). "Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia". Haematologica. 88 (1): 13–8. PMID 12551821.
- ↑ Berlin, NI. (1975). "Diagnosis and classification of polycythemias". Semin Hematol 12: 339.